Immuron Limited Gains 63.42%

Mon 20 Jul 20 at 05:33 PM
Immuron Limited Gains 63.42%

Immuron Limited (IMRN:NASDAQ) shot up at $10.41, representing a gain of 63.4%. The stock appeared on our News Catalysts scanner on Mon 20 Jul 20 at 06:43 AM in the 'BIOTECH' category. From Mon 06 Jul 20, the stock recorded 33.33% Up Days and 40.00% Green Days

The stock spiked on Fri 19 Jun 20 at $12.78 with a volume of 4M+, and its share price has been moving sideways in recent weeks.

About Immuron Limited (IMRN:NASDAQ)

Immuron Ltd is a biopharmaceutical company which develops polyclonal antibodies for the treatment and prevention of diseases. It products include Travelan, IMM-124E for NASH and IMM-529 for Clostridium difficile infection.